Literature DB >> 16352909

Hallucinations, cognitive decline, and death in Alzheimer's disease.

R S Wilson1, Y Tang, N T Aggarwal, D W Gilley, J J McCann, J L Bienias, D A Evans.   

Abstract

The relation of psychotic symptoms to cognitive decline and mortality in Alzheimer's disease (AD) was examined during a mean of 2.2 years in 478 persons selected from clinical settings. Psychotic symptoms were ascertained at baseline and cognition was assessed semiannually with nine tests from which a global measure was formed. In analyses that controlled for age, sex, race, and education, hallucinations (29.6%), especially visual ones, were associated with more rapid global cognitive decline and increased mortality, even after controlling for baseline level of cognition and use of antipsychotic medication, and the association with mortality increased with higher level of education. Delusions and misperceptions were not strongly related to cognitive decline or mortality. The results suggest that hallucinations in Alzheimer's disease, particularly visual ones, are associated with more rapid progression. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352909     DOI: 10.1159/000090251

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  24 in total

Review 1.  Genetics of psychosis of Alzheimer disease.

Authors:  Chintan Shah; Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-01-12       Impact factor: 3.568

2.  Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.

Authors:  Sandra Barral; Badri N Vardarajan; Dolly Reyes-Dumeyer; Kelley M Faber; Thomas D Bird; Debby Tsuang; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Rafael Lantigua; Martin Z Medrano; Xinbing Wang; M Ilyas Kamboh; Mahmud Muhiedine Barmada; Daniel J Schaid; Tatiana M Foroud; Elise A Weamer; Ruth Ottman; Robert A Sweet; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2015-08-15       Impact factor: 4.673

3.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

4.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 5.  Psychosis in Alzheimer's disease.

Authors:  Patrick S Murray; Sanjeev Kumar; Mary Ann A Demichele-Sweet; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2013-10-06       Impact factor: 13.382

Review 6.  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.

Authors:  Dilip V Jeste; Dan Blazer; Daniel Casey; Thomas Meeks; Carl Salzman; Lon Schneider; Pierre Tariot; Kristine Yaffe
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

7.  Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.

Authors:  Reena T Gottesman; Anton Kociolek; Kayri Fernandez; Stephanie Cosentino; D P Devanand; Yaakov Stern; Yian Gu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Association Between Caregivers' Burden and Neuropsychiatric Symptoms in Female Patients with Alzheimer's Disease with Varying Dementia Severity.

Authors:  Yu-An Chen; Cheng-Chen Chang; Wen-Fu Wang; Ya-Sian Lin; Kai-Ming Jhang; Tzu-Ying Lo; Hsin-Hung Wu
Journal:  J Multidiscip Healthc       Date:  2021-04-28

9.  Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.

Authors:  Manuel Fernández; Ana L Gobartt; Montse Balañá
Journal:  BMC Neurol       Date:  2010-09-28       Impact factor: 2.474

Review 10.  Frontotemporal dementia to Alzheimer's disease.

Authors:  Maria Caterina Silveri
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.